Dirksen Bussiere

Company: Lilly Oncology

Job title: Associate Vice President - Molecular Pharmacology

Seminars:

Presentation Q&A & Panel Discussion: Overcoming Challenges in HIT Discovery with Innovative Applications of Biophysics 10:00 am

Hear from our expert speakers on overcoming the multifaceted challenges in HIT Discovery by utilizing a range of innovative approaches. Delve into discussions surrounding the tailored biophysical approaches, leveraging DNA encoded libraries and fragment-based screening. Hear experiences, insights, and strategies for navigating the complexities of optimizing hit identification while balancing efficiency and minimizing false positivesRead more

day: Conference Day One

Application of Fragment-Based Screening & Fragment-Based Drug Discovery to the Development of Cancer Therapeutics 9:30 am

Unveiling the potential of Fragment-Based Screening (FBS) in identifying hits on challenging targets Leveraging NMR and SPR in understanding molecular interactions and real-time detection of molecular binding events Best practices to overcome the weak interactions of fragment-based screeningRead more

day: Conference Day One